The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
A 45-year-old premenopausal woman presented with multifocal cancer in the right breast, with lesions at 1: 00 and 4:00, the largest measuring approximately 3 cm on exam, and multiple palpable right axillary lymph nodes. A core biopsy confirmed invasive ductal carcinoma, grade 2 of 3, that was estrogen receptor positive, progesterone receptor positive, and HER2 negative. Fine needle aspiration of a right axillary node confirmed metastatic carcinoma. A positron emission tomography (PET)/ computed tomography done before starting chemotherapy demonstrated an absence of metastatic disease with expected avidity in two separate breast masses and multiple conglomerated 1-2 cm level I and II axillary lymph nodes. She received neoadjuvant chemotherapy with doxorubicin plus cyclophosphamide, followed by paclitaxel, and had a complete clinical response with resolution of the breast and axillary masses on exam. A repeat PET/computed tomography demonstrated reduced size of the breast and axillary disease, and no significant residual PET avidity. Her breast surgeon recommended a right mastectomy with axillary node dissection. As part of her multidisciplinary treatment plan, she consulted with two plastic surgeons to discuss reconstruction options. Plastic Surgeon A advised placement of an implant at the time of mastectomy while Surgeon B contrasted the pros and cons of an autologous transverse rectus abdominis muscle flap reconstruction with an implant based reconstruction. Surgeon B believed that autologous reconstruction would yield the best long-term cosmetic outcome. Before making her surgery decision, the patient consulted with a radiation oncologist to discuss the effect radiation may have on her reconstruction outcome.
CHALLENGES IN DIAGNOSIS AND MANAGEMENT
This case highlights the difficult decisions women face with breast reconstruction and how radiation may complicate those choices. She should receive post mastectomy radiation therapy (PMRT). PMRT improves local control, disease-free and overall survival for stage II/III women with breast cancer. [1] [2] [3] For several decades, PMRT was mainly reserved for women with four or more positive lymph nodes but is now frequently recommended for women with one to three positive lymph nodes, after a meta-analysis demonstrated a disease-free and overall survival improvement for women with even one positive lymph node. 4, 5 There may be a role for PMRT in women with node-negative breast cancer, though this remains controversial. [6] [7] [8] [9] [10] Increasing numbers of women are choosing breast reconstruction after mastectomy.
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Women must consider the timing of reconstruction and whether to use prosthetic devices or natural tissue to recreate the breast mound. Immediate reconstruction is performed at the time of mastectomy, whereas delayed reconstruction is performed some time after the mastectomy, typically after the completion of adjuvant treatments. Placement of a temporary tissue expander at the time of reconstruction, with subsequent exchange for a permanent implant, is often termed delayed-immediate or staged reconstruction, although many publications, including the Mastectomy Reconstruction Outcomes Consortium study in this issue by Pusic et al, categorize this as immediate.
14 Many surgeons favor immediate reconstruction to minimize the period of amastia, and because the mastectomy skin is often pliable and can be easily incorporated into the reconstruction, which is not always the case at delayed reconstruction, particularly after adjuvant radiation.
Autologous reconstruction makes use of the patient's own tissues (skin/fat/muscle), whereas an implant-based reconstruction makes use of a prosthetic device, such as a commercially available saline or silicone implant. When both approaches are used, the reconstruction is typically categorized as autologous because some of the patient's own tissue is used to augment or repair the traumatized mastectomy tissue. Autologous tissue reconstruction has the advantages that come with avoiding an artificial device, however, at the expense of a longer operation, a second donor site surgical wound, and longer healing/recovery times. As a prosthetic device, a breast implant has the potential for infection, capsular tightening and implant rupture. When the transferred autologous tissue lacks sufficient volume to create a full breast, a prosthetic implant can be combined with the flap. Autologous tissue-based breast reconstruction includes pedicled flaps and free flaps. Pedicled flaps are rotated into place with an intact blood supply. Free flaps have their vascular supply severed and connected to a new blood supply through microvascular surgery.
The soft tissues of the lower abdomen are a very common source of tissue for breast reconstruction. The transverse rectus abdominis muscle (TRAM) flap is a pedicled flap and is a mainstay option for breast reconstruction, and often provides enough tissue volume to avoid adding a prosthetic. A latissimus dorsi (LD) flap can be crafted in women when the abdomen has had prior surgery, and results in a shorter recovery time than a TRAM flap, but often necessitates a prosthesis for adequate breast volume. Over the past several years there has been an increase in the use of muscle preserving perforator flaps, such as the deep inferior epigastric perforator (DIEP) flap. The gluteal region, superior or inferior gluteal artery perforator (SGAP/IGAP) and the thigh region, transverse upper gracilis (TUG) can provide suitable tissues particularly when the abdomen is compromised due to scarring or body habitus.
Autologous reconstruction, particularly free tissue transfer, often requires additional training and expertise, and is not performed in all medical centers. An implant-based reconstruction can spare the patient additional operative time and donor site healing and commonly results in excellent aesthetic results, particularly if the patient does not require PMRT. Figure 1 provides an early postoperative photographic comparison of the two techniques in patients who underwent radiation as part of their adjuvant cancer treatment.
Regardless of the timing or technique of reconstruction, complications can occur. 15 Perioperative complications include infection and wound healing problems. The breast implant may need to be removed due to infection or capsular contracture and an autologous flap can sometimes fail due to occlusion of its blood supply. Nevertheless, patient satisfaction with postmastectomy reconstruction remains high.
SUMMARY OF THE RELEVANT LITERATURE

Implant-Based Reconstruction
Retrospective studies indicate that PMRT further increases the postoperative complication rate. [16] [17] [18] [19] [20] [21] [22] [23] Benediktsson et al reported that 22 of 107 patients developed significant, Baker 3 or 4 contracture following implant reconstruction, with 16 of 22 patients requiring reoperation. The contracture rate was 41.7% after PMRT, compared with14.5% without radiation (P 5 .01). 18 Cordeiro et al published the retrospective Memorial Sloan Kettering Cancer Center experience from 1995-2001 of immediate tissue expander (TE) followed by implant reconstruction 4 weeks after chemotherapy followed by PMRT and compared this is to a cohort of nonradiated reconstructed patients. Of the 687 reconstructed patients, 68 had PMRT of whom 39.7% developed Baker 3 or 4 contractures compared with the rate of 10.6% among nonradiated patients. Both cohorts reported high rates of good to excellent aesthetic results. 20 The Michigan Breast Reconstruction Outcomes Study (MBROS) was initiated in 1994, with 12 hospitals across the United States and Canada participating. A subset of 74 patients from the MBROS dataset of immediate implant reconstruction patients were evaluated for RT complications, defined as any infection, contracture, wound dehiscence, deflation, rupture, hematoma, seroma, lymphedema, and/or back pain. Using that definition, 68% of the radiated group and 31% of the nonradiated group developed a reconstruction complication. Failure rate (removal) of the implant was 37% with radiation therapy (RT) and 8% without.
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Immediate tissue expander followed by subsequent bilateral implant reconstruction in the setting of prior right breast radiation Immediate tissue expander followed by PMRT to the left chest wall with subsequent bilateral free-flap autologous reconstruction In summary, significant reconstruction complications occur with implant-based reconstruction without PMRT, but PMRT likely increases the complication rate by two to threefold.
Autologous Reconstruction
Similarly, PMRT increases the rate of complications following autologous reconstruction; again by approximately two to threefold. Christante et al from Oregon Health Sciences University (OHSU) identified 302 mastectomy patients in a hospital database between 2000 and 2008, of whom 152 (50%) underwent reconstruction (131 immediate, 22 delayed). The complication rate, defined as an unplanned reoperation, was 13% for the entire cohort, 16% for immediate autologous breast reconstruction patients and 42% for those receiving PMRT. 19 Of the 100 PMRT patients, 44% of immediate reconstruction and 22% of delayed reconstruction patients experienced a complication (P 5 .44). In a multivariate model, PMRT increased complications threefold (hazard ratio [HR], 3.3; 1.5-7.1, P 5 .001) as did immediate breast reconstruction (HR, 8.1; 3.2-20, P , .001), over mastectomy alone. For patients who had combined implant plus autologous reconstruction, the implant removal rate was 31% v 6% for radiated versus nonradiated patients (P 5 .005). Spear et al from Georgetown University Medical Center reviewed 150 TRAM flaps with three groups: preflap RT, postflap RT or no PMRT. The total complication rate was 49.5% with no difference seen among the three groups. Rates of complete necrosis were , 1%, and partial necrosis 7.6%, again without significant difference among the three groups. Radiation therapy diminished the cosmetic outcomes. Among those treated with radiation, the preflap RT group reported best cosmesis. 25 
Head-to-Head Comparison
Multiple investigators have compared outcomes for implant and autologous tissue reconstructions. Christensen et al from Denmark conducted a retrospective chart review and patient questionnaire from 1990 to 2005 throughout the central and northern Denmark regions to compare the outcomes of various reconstruction techniques, identifying 137 implant and 126 autologous (100 TRAM, 26 LD reconstruction cases. 26 Women with autologous tissue were significantly more pleased (81% LD, 84% TRAM) with their reconstructed breast than women with an implant (64%, P 5.002),. There was no difference in reconstruction complications, based on technique, though smokers did worse with an implant, and overweight patients did worse with autologous flaps. Alderman et al analyzed 175 patients from the MBROS for satisfaction with breast reconstruction 2 years after surgery.
27 70% of autologous patients were satisfied with their aesthetic outcomes compared with only 43% of patients with implants. Rates of complications were higher in immediate as opposed to delayed reconstruction (52% v 32%), but no significant difference was found between implant and autologous reconstruction.
17 Radiation increased the complication rate with an HR 1.76, P 5.057.
The publication by Pusic et al from the Mastectomy Reconstruction Outcomes Consortium Study is one of the largest patient reported outcome reports to evaluate implant and autologous reconstructions.
14 Investigators from 11 treatment centers shared data from 1,632 patients (1,139 implant and 493 autologous) who completed reliable quality of life instruments such as the BREAST-Q and PROMIS-29 validated survey tools, specific for post mastectomy patient satisfaction. The reconstruction method was based on surgeon and patient preference, and was not randomized. Approximately 25% of patients had PMRT, with twice as many receiving PMRT in the autologous reconstruction group (30.5% v 16.7%). Major complications occurred in 21.1% of autologous and 9.4% of implant patients (P , .001). This difference may be due to the higher utilization of PMRT after autologous reconstruction.
Following autologous reconstruction, patients reported greater satisfaction with their breasts, as well as improved sexual and psychosocial well-being at 1 year compared with patients with implant reconstruction. Autologous reconstruction was associated with more pain and fatigue than implant reconstruction.
In summary, implant and autologous tissue-based breast reconstruction appear to have a similar complication rates; however autologous patients appear to have an increased satisfaction with their reconstruction and report improved psychosocial outcomes, even in the setting of increased rates of PMRT. PMRT and immediate reconstructions are linked to higher complication rates after breast reconstruction, and autologous implants may be associated with better cosmetic outcome and patient psychosocial well-being. We discussed two possible approaches with this patient, factoring in her preference for postmastectomy reconstruction, and her need for postmastectomy radiotherapy. Our practice for patients like this, who require PMRT and are interested in reconstruction, would be either delayed autologous reconstruction or a delayed-immediate reconstruction protocol consisting of immediate TE placement and inflation, followed by PMRT, followed by expander removal and autologous reconstruction (Fig 2) . This patient ultimately chose to have an autologous breast reconstruction. Her mastectomy revealed a complete resolution of disease in the breast and two of 12 lymph nodes contained macrometastasis, upon axilla dissection. She had a tissue expander placed at the time of her mastectomy, which was inflated to size over a 4 week time period. She completed PMRT with transient grade 2 dermatitis, and 4 months later received a DIEP free flap. Now 2 years after her reconstruction, both the patient and her oncology team are pleased with her outcome.
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